Drug Fails to Show Significant Improvement in Depression Metrics The drug did not achieve statistically significant results on MADRS and SHAPS scales, highlighting the challenges in depression treatment efficacy.
Drug Fails to Show Significant Improvement in Depression The recent trial of a new drug for depression did not achieve statistically significant results in improving symptoms. Stay informed on mental health treatments.
Neumora's Depression Drug Trial Fails, Shares Plunge 82% Neumora Therapeutics' depression drug falls short in final-stage trial, leading to an 82% pre-market share drop. Discover the impact on Neumora's future prospects.